Strategic Partnerships Stocks
Asset-heavy operators and research-intensive developers in this cohort leverage joint ventures, royalty structures, and licensing agreements to mitigate high capital expenditures and clinical risk.
As of Oct 23, 2026, Strategic Partnerships has 60 US-listed companies worth $1.1T combined. The median member moved +0.2% over the past week; SEPN led among the 25 largest at +11.2% and SECZ trailed at -20.9%.
Companies in Strategic Partnerships
- SKHY – SK Hynix Inc. American Depositary Shares, $960B
- EXR – Extra Space Storage Inc, $31.6B
- OMC – Omnicom Group Inc, $22.7B
- EXE – Expand Energy Corporation, $21.5B
- TLN – Talen Energy Corporation, $15.5B
- ASTS – Ast Spacemobile Inc, $15.1B
- AMG – Affiliated Managers Group, Inc., $9.9B
- EVR – Evercore Partners Inc, $9.8B
- PTGX – Protagonist Therapeutics Inc, $9B
- MP – MP Materials Corp, $6.8B
- LGND – Ligand Pharmaceuticals Incorporated, $6.1B
- PBLS – Parabilis Medicines, Inc. Common Stock, $3.1B
- NRIX – Nurix Therapeutics Inc, $2.9B
- RCUS – Arcus Biosciences Inc, $2.8B
- SA – Seabridge Gold Inc., $2.8B
- ZLAB – Zai Lab Ltd, $2.7B
- ALM – Almonty Industries Inc. Common Shares, $2.5B
- NVAX – Novavax Inc, $1.9B
- SEPN – Septerna, Inc. Common Stock, $1.8B
- NUVB – Nuvation Bio Inc, $1.7B
- SECZ – Securitize Corp., $1.5B
- PWP – Perella Weinberg Partners, $1.3B
- USPH – U.S. Physical Therapy, Inc., $1.2B
- KURA – Kura Oncology Inc, $944M
- RJET – Republic Airways Holdings Inc, $826M
- WVE – Wave Life Sciences Ltd, $745M
- CNNE – Cannae Holdings Inc, $685M
- CTMX – CytomX Therapeutics Inc, $556M
- TMQ – Trilogy Metals Inc, $539M
- WRN – Western Copper and Gold Corp, $461M
- ALTI – Alvarium Tiedemann Holdings Inc., $419M
- ASMB – Assembly Biosciences Inc, $409M
- SCTX – Scribe Therapeutics Inc. Common Stock, $380M
- OBIO – Orchestra BioMed Holdings Inc., $358M
- PPHC – Public Policy Holding Company, Inc. Common Stock, $336M
- CCCC – C4 Therapeutics Inc, $325M
- CTNM – Contineum Therapeutics, Inc. Class A Common Stock, $266M
- RWAY – Runway Growth Finance Corp, $266M
- AIRJ – AirJoule Technologies Corporation, $265M
- ACIU – AC Immune Ltd, $256M
- LCTX – Lineage Cell Therapeutics Inc, $251M
- USDE – StablecoinX Inc. Class A Common Stock, $245M
- MGNX – MacroGenics Inc, $218M
- CAMP – CAMP4 THERAPEUTICS CORPORATION, $215M
- PRQR – ProQR Therapeutics BV, $195M
- MOLN – Molecular Partners AG ADR, $165M
- VRXA – Veraxa Biotech AG Ordinary Shares, $156M
- OGI – OrganiGram Holdings Inc, $132M
- VYGR – Voyager Therapeutics Inc, $117M
- SPRO – Spero Therapeutics Inc, $71.6M
- FBIO – Fortress Biotech Inc, $67.7M
- HOWL – Werewolf Therapeutics Inc, $45.2M
- INV – Innventure, Inc., $28.4M
- ANPA – Rich Sparkle Holdings Limited Ordinary Shares, $25.8M
- KPRX – Kiora Pharmaceuticals Inc, $10.9M
- PULM – Pulmatrix Inc, $5.7M
- ADXN – Addex Therapeutics Ltd, $5.4M
- EGLE – Eagle Bulk Shipping Inc
- MBNKO – Medallion Bank
- TNIE – Tonies SE Class A